DNA methylation regulates the expression of CXCL12 in rheumatoid arthritis synovial fibroblasts

Genes and Immunity

Volumn 12, Issue 8, 2011, Pages 643-652

  Karouzakis, E ^a   Rengel, Y ^a   Jungel A ^a   Kolling, C ^b   Gay, R E ^a   Michel, B A ^a   Tak, P P ^c   Gay, S ^a   Neidhart, M ^a   Ospelt, C ^a,c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b SCHULTHESS CLINIC   (Switzerland)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

CXCL12; DNA methylation; epigenetics; rheumatoid arthritis synovial fibroblasts

Indexed keywords

AZACITIDINE; CHEMOKINE RECEPTOR CXCR4; MATRIX METALLOPROTEINASE; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; DNA METHYLATION; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; JOINT DESTRUCTION; OSTEOARTHRITIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIUM;

AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; CHEMOKINE CXCL12; DNA METHYLATION; FEMALE; FIBROBLASTS; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; PROMOTER REGIONS, GENETIC; RECEPTORS, CXCR; RNA INTERFERENCE; SYNOVIAL MEMBRANE; UP-REGULATION;

EID: 82555192432     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2011.45     Document Type: Article

References (64)

1. Ospelt C, Gay S. The role of resident synovial cells in destructive arthritis. Best Pract Res Clin Rheumatol 2008; 22: 239-252. (Pubitemid 351606943)
2. Karouzakis E, Gay RE, Michel BA, Gay S, Neidhart M. DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 2009; 60: 3613-3622.
3. Wade PA. Methyl CpG-binding proteins and transcriptional repression. Bioessays 2001; 23: 1131-1137.
4. Reik W, Dean W, Walter J. Epigenetic reprogramming in mammalian development. Science 2001; 293: 1089-1093. (Pubitemid 32758081)
5. Hewagama A, Richardson B. The genetics and epigenetics of autoimmune diseases. J Autoimmun 2009; 33: 3-11.
6. Esteller M. Epigenetics in cancer. N Engl J Med 2008; 358: 1148-1159.
7. Petit I, Jin D, Rafii S. The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol 2007; 28: 299-307. (Pubitemid 46963141)
8. Kucia M, Jankowski K, Reca R, Wysoczynski M, Bandura L, Allendorf DJ et al. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 2004; 35: 233-245. (Pubitemid 40585309)
9. Burns JM, Summers BC, Wang Y, Melikian A, Berahovich R, Miao Z et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 2006; 203: 2201-2213. (Pubitemid 44352240)
10. Raggo C, Ruhl R, McAllister S, Koon H, Dezube BJ, Fruh K et al. Novel cellular genes essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus. Cancer Res 2005; 65: 5084-5095. (Pubitemid 40827317)
11. Miao Z, Luker KE, Summers BC, Berahovich R, Bhojani MS, Rehemtulla A et al. CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc Natl Acad Sci USA 2007; 104: 15735-15740. (Pubitemid 350035369)
12. De Paepe B, Schroder JM, Martin JJ, Racz GZ, De Bleecker JL. Localization of the alpha-chemokine SDF-1 and its receptor CXCR4 in idiopathic inflammatory myopathies. Neuromuscul Disord 2004; 14: 265-273. (Pubitemid 38326848)
13. Gu J, Marker-Hermann E, Baeten D, Tsai WC, Gladman D, Xiong M et al. A 588-gene microarray analysis of the peripheral blood mononuclear cells of spondyloarthropathy patients. Rheumatology (Oxford) 2002; 41: 759-766. (Pubitemid 34822958)
14. Krumbholz M, Theil D, Cepok S, Hemmer B, Kivisakk P, Ransohoff RM et al. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain 2006; 129(part 1): 200-211. (Pubitemid 43063771)
15. Kryczek I, Wei S, Keller E, Liu R, Zou W. Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis. Am J Physiol Cell Physiol 2007; 292: C987-C995. (Pubitemid 46440396)
16. Kanbe K, Takagishi K, Chen Q. Stimulation of matrix metalloprotease 3 release from human chondrocytes by the interaction of stromal cell-derived factor 1 and CXC chemo-kine receptor 4. Arthritis Rheum 2002; 46: 130-137. (Pubitemid 34121659)
17. Nanki T, Hayashida K, El-Gabalawy HS, Suson S, Shi K, Girschick HJ et al. Stromal cell-derived factor-1-CXC chemo-kine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium. J Immunol 2000; 165: 6590-6598.
18. Burger JA, Zvaifler NJ, Tsukada N, Firestein GS, Kipps TJ. Fibroblast-like synoviocytes support B-cell pseudoemperi-polesis via a stromal cell-derived factor-1-and CD106 (VCAM-1)-dependent mechanism. J Clin Invest 2001; 107: 305-315. (Pubitemid 32157962)
19. Nanki T, Nagasaka K, Hayashida K, Saita Y, Miyasaka N. Chemokines regulate IL-6 and IL-8 production by fibroblast-like synoviocytes from patients with rheumatoid arthritis. J Immunol 2001; 167: 5381-5385. (Pubitemid 33009778)
20. Blades MC, Ingegnoli F, Wheller SK, Manzo A, Wahid S, Panayi GS et al. Stromal cell-derived factor 1 (CXCL12) induces monocyte migration into human synovium transplanted onto SCID Mice. Arthritis Rheum 2002; 46: 824-836. (Pubitemid 34214266)
21. Watanabe N, Ando K, Yoshida S, Inuzuka S, Kobayashi M, Matsui N et al. Gene expression profile analysis of rheumatoid synovial fibroblast cultures revealing the overexpression of genes responsible for tumor-like growth of rheumatoid synovium. Biochem Biophys Res Commun 2002; 294: 1121-1129. (Pubitemid 34687166)
22. Grassi F, Cristino S, Toneguzzi S, Piacentini A, Facchini A, Lisignoli G. CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients. J Cell Physiol 2004; 199: 244-251. (Pubitemid 38436751)
23. Garcia-Vicuna R, Gomez-Gaviro MV, Dominguez-Luis MJ, Pec MK, Gonzalez-Alvaro I, Alvaro-Gracia JM et al. CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast-like synoviocytes from rheumatoid arthritis patients. Arthritis Rheum 2004; 50: 3866-3877. (Pubitemid 39643933)
24. Kanbe K, Takemura T, Takeuchi K, Chen Q, Takagishi K, Inoue K. Synovectomy reduces stromal-cell-derived factor-1 (SDF-1) which is involved in the destruction of cartilage in osteoarthritis and rheumatoid arthritis. J Bone Joint Surg Br 2004; 86: 296-300. (Pubitemid 38386874)
25. Kondo Y, Issa JP. Epigenetic changes in colorectal cancer. Cancer Metastasis Rev 2004; 23: 29-39. (Pubitemid 38221595)
26. Lin CH, Hsieh SY, Sheen IS, Lee WC, Chen TC, Shyu WC et al. Genome-wide hypomethylation in hepatocellular carcino-genesis. Cancer Res 2001; 61: 4238-4243.
27. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349: 2042-2054. (Pubitemid 37448928)
28. Weisenberger DJ, Campan M, Long TI, Kim M, Woods C, Fiala E et al. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res 2005; 33: 6823-6836. (Pubitemid 41830488)
29. Roman-Gomez J, Jimenez-Velasco A, Agirre X, Cervantes F, Sanchez J, Garate L et al. Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia. Oncogene 2005; 24: 7213-7223. (Pubitemid 41679283)
30. Richardson B. Primer: epigenetics of autoimmunity. Nat Clin Pract Rheumatol 2007; 3: 521-527. (Pubitemid 47351397)
31. Lu Q, Wu A, Richardson BC. Demethylation of the same promoter sequence increases CD70 expression in lupus Tcells and Tcells treated with lupus-inducing drugs. J Immunol 2005; 174: 6212-6219. (Pubitemid 40663812)
32. Kaplan MJ, Lu Q, Wu A, Attwood J, Richardson B. Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells. J Immunol 2004; 172: 3652-3661. (Pubitemid 38337948)
33. Oelke K, Lu Q, Richardson D, Wu A, Deng C, Hanash S et al. Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors. Arthritis Rheum 2004; 50: 1850-1860. (Pubitemid 38725098)
34. Calonge E, Alonso-Lobo JM, Escandon C, Gonzalez N, Bermejo M, Santiago B et al. c/EBPbeta is a major regulatory element driving transcriptional activation of the CXCL12 promoter. J Mol Biol 2010; 396: 463-472.
35. Ceradini DJ, Gurtner GC. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc Med 2005; 15: 57-63. (Pubitemid 40693388)
36. Garcia-Moruja C, Alonso-Lobo JM, Rueda P, Torres C, Gonzalez N, Bermejo M et al. Functional characterization of SDF-1 proximal promoter. J Mol Biol 2005; 348: 43-62. (Pubitemid 40461839)
37. Wendt MK, Johanesen PA, Kang-Decker N, Binion DG, Shah V, Dwinell MB. Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis. Oncogene 2006; 25: 4986-4997.
38. Wendt MK, Cooper AN, Dwinell MB. Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells. Oncogene 2008; 27: 1461-1471. (Pubitemid 351317456)
39. Pietkiewicz PP, Lutkowska A, Lianeri M, Jagodzinski PP. Tamoxifen epigenetically modulates CXCL12 expression in MCF-7 breast cancer cells. Biomed Pharmacother 2010; 64: 54-57.
40. Bradfield PF, Amft N, Vernon-Wilson E, Exley AE, Parsonage G, Rainger GE et al. Rheumatoid fibroblast-like synoviocytes overexpress the chemokine stromal cell-derived factor 1 (CXCL12), which supports distinct patterns and rates of CD4+ and CD8+ T cell migration within synovial tissue. Arthritis Rheum 2003; 48: 2472-2482. (Pubitemid 37129424)
41. del Rey MJ, Izquierdo E, Caja S, Usategui A, Santiago B, Galindo M et al. Human inflammatory synovial fibroblasts induce enhanced myeloid cell recruitment and angiogenesis through a hypoxia-inducible transcription factor 1alpha/vascular endothelial growth factor-mediated pathway in immunodeficient mice. Arthritis Rheum 2009; 60: 2926-2934.
42. Pablos JL, Santiago B, Galindo M, Torres C, Brehmer MT, Blanco FJ et al. Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis. J Immunol 2003; 170: 2147-2152. (Pubitemid 36197438)
43. Sato N, Matsubayashi H, Fukushima N, Goggins M. The chemokine receptor CXCR4 is regulated by DNA methylation in pancreatic cancer. Cancer Biol Ther 2005; 4: 70-76. (Pubitemid 41350934)
44. Law NM, Rosenzweig SA. Characterization of the G-protein linked orphan receptor GPRN1/RDC1. Biochem Biophys Res Commun 1994; 201: 458-465.
45. Balabanian K, Lagane B, Infantino S, Chow KY, Harriague J, Moepps B et al. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem 2005; 280: 35760-35766. (Pubitemid 41532769)
46. Infantino S, Moepps B, Thelen M. Expression and regulation of the orphan receptor RDC1 and its putative ligand in human dendritic and B cells. J Immunol 2006; 176: 2197-2207. (Pubitemid 43201667)
47. Zabel BA, Wang Y, Lewen S, Berahovich RD, Penfold ME, Zhang P et al. Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands. J Immunol 2009; 183: 3204-3211.
48. Kalatskaya I, Berchiche YA, Gravel S, Limberg BJ, Rosenbaum JS, Heveker N. AMD3100 is a CXCR7 ligand with allosteric agonist properties. Mol Pharmacol 2009; 75: 1240-1247.
49. 00 receptor CXCR7. Proc Natl Acad Sci USA 2010; 107: 628-632.
50. Gurevich EV, Gurevich VV. Arrestins: ubiquitous regulators of cellular signaling pathways. Genome Biol 2006; 7: 236.
51. Konttinen YT, Ainola M, Valleala H, Ma J, Ida H, Mandelin J et al. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis 1999; 58: 691-697. (Pubitemid 29517255)
52. Jungel A, Ospelt C, Lesch M, Thiel M, Sunyer T, Schorr O et al. Effect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis. Ann Rheum Dis 2010; 69: 898-902.
53. Rutkauskaite E, Zacharias W, Schedel J, Muller-Ladner U, Mawrin C, Seemayer CA et al. Ribozymes that inhibit the production of matrix metalloproteinase 1 reduce the invasive-ness of rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 2004; 50: 1448-1456. (Pubitemid 38608066)
54. Iliopoulos D, Malizos KN, Tsezou A. Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondro-cytes: possible molecular target for osteoarthritis therapeutic intervention. Ann Rheum Dis 2007; 66: 1616-1621. (Pubitemid 350205450)
55. Roach HI, Yamada N, Cheung KS, Tilley S, Clarke NM, Oreffo RO et al. Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondro-cytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum 2005; 52: 3110-3124. (Pubitemid 41447092)
56. Couillard J, Demers M, Lavoie G, St-Pierre Y. The role of DNA hypomethylation in the control of stromelysin gene expression. Biochem Biophys Res Commun 2006; 342: 1233-1239.
57. Ogata Y, Enghild JJ, Nagase H. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem 1992; 267: 3581-3584.
58. Goldberg GI, Strongin A, Collier IE, Genrich LT, Marmer BL. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem 1992; 267: 4583-4591.
59. Benbow U, Brinckerhoff CE. The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol 1997; 15: 519-526. (Pubitemid 27190026)
60. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324. (Pubitemid 18091653)
61. Ospelt C, Kurowska-Stolarska M, Neidhart M, Michel BA, Gay RE, Laufer S et al. The dual inhibitor of lipoxygenase and cyclooxygenase ML3000 decreases the expression of CXCR3 ligands. Ann Rheum Dis 2007; 67: 524-529. (Pubitemid 351498435)
62. Li LC, Dahiya R. MethPrimer: designing primers for methyla-tion PCRs. Bioinformatics 2002; 18: 1427-1431. (Pubitemid 35414532)
63. Bock C, Reither S, Mikeska T, Paulsen M, Walter J, Lengauer T. BiQ Analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing. Bioinformatics 2005; 21: 4067-4068. (Pubitemid 41631851)
64. Distler JH, Jungel A, Huber LC, Seemayer CA, Reich III CF, Gay RE et al. The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles. Proc Natl Acad Sci USA 2005; 102: 2892-2897. (Pubitemid 40299887)